ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.49413G>T (p.Trp16471Cys) (rs202094100)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000248683 SCV000318684 uncertain significance Cardiovascular phenotype 2013-05-26 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000184581 SCV000281414 uncertain significance not provided 2016-04-08 criteria provided, single submitter clinical testing Converted during submission to Uncertain significance.
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000184581 SCV000701050 uncertain significance not provided 2018-06-18 criteria provided, single submitter clinical testing
Fulgent Genetics,Fulgent Genetics RCV000764335 SCV000895354 uncertain significance Dilated cardiomyopathy 1G; Limb-girdle muscular dystrophy, type 2J; Distal myopathy Markesbery-Griggs type; Hereditary myopathy with early respiratory failure; Myopathy, early-onset, with fatal cardiomyopathy; Familial hypertrophic cardiomyopathy 9 2018-10-31 criteria provided, single submitter clinical testing
GeneDx RCV000040300 SCV000237249 uncertain significance not specified 2017-09-18 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the TTN gene. The W14830C variant, also denoted asW13903C due to the use of an alternate transcript, has been previously reported in a six month old Caucasian malewith a clinical diagnosis of DCM, and no history of skeletal myopathy or family history of DCM (Pugh et al., 2014).However, this individual also harbored additional cardiogenetic variants. Additionally, the W14830Cvariant is observed in 42/66,500 (0.06%) alleles from individuals of Non-Finnish European ancestry in largepopulation cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The W14830Cvariant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as theseresidues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conservedacross species, and in silico analysis predicts this variant is probably damaging to the protein structure/function.However, although W14830C is located in the A-band region of titin, the majority of pathogenic variants in the TTNgene associated with DCM are truncating variants in this region (Herman et al., 2012). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Illumina Clinical Services Laboratory,Illumina RCV000357355 SCV000423019 uncertain significance Myopathy, early-onset, with fatal cardiomyopathy 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000262625 SCV000423020 uncertain significance Hypertrophic cardiomyopathy 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000317820 SCV000423021 uncertain significance Dilated Cardiomyopathy, Dominant 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000372520 SCV000423022 uncertain significance Hereditary myopathy with early respiratory failure 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000275689 SCV000423023 uncertain significance Distal myopathy Markesbery-Griggs type 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000330719 SCV000423024 uncertain significance Limb-Girdle Muscular Dystrophy, Recessive 2016-06-14 criteria provided, single submitter clinical testing
Invitae RCV000560033 SCV000643276 uncertain significance Dilated cardiomyopathy 1G; Limb-girdle muscular dystrophy, type 2J 2017-12-14 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000040300 SCV000063991 uncertain significance not specified 2018-11-02 criteria provided, single submitter clinical testing proposed classification - variant undergoing re-assessment, contact laboratory

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.